LARIMAR THERAPEUTICS Trademark

Trademark Overview


On Friday, July 17, 2020, a trademark application was filed for LARIMAR THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the LARIMAR THERAPEUTICS trademark a serial number of 90059153. The federal status of this trademark filing is REGISTERED as of Tuesday, March 26, 2024. This trademark is owned by Chondrial Therapeutics, Inc.. The LARIMAR THERAPEUTICS trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Pharmaceutical preparations for the treatment of mitochondrial disorders; Pharmaceutical preparations and substances for treatment of genetic diseases; pharmaceutical preparations for the treatment of diseases or dysfunction of the mitochondria; pharmaceutical preparations featuring cell penetrating peptides for use in the treatment of genetic disorders; pharmaceuticals that treat genetic diseases by use of carrier proteins; pharmaceutical preparations for the treatment of ataxia; pharmaceutical preparations for the treatment of Friedreich's Ataxia; pharmaceutical preparations for protein replacement therapy

Pharmaceutical research and development; research and development in the pharmaceutical and biotechnology fields; research in the field of pharmaceuticals and drugs; conducting genomic analysis, pre-clinical studies and clinical trials for others in the field of pharmaceutical preparations for treatment of diseases
larimar therapeutics

General Information


Serial Number90059153
Word MarkLARIMAR THERAPEUTICS
Filing DateFriday, July 17, 2020
Status700 - REGISTERED
Status DateTuesday, March 26, 2024
Registration Number7340237
Registration DateTuesday, March 26, 2024
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, January 5, 2021

Trademark Statements


Description of MarkThe mark consists of the stylized word "Larimar" in black with a blue letter "i" above the word "Therapeutics" in black; extending from the dot of the letter is s a curled ribbon in the colors blue, teal, and white; the remaining color white represents a transparent background which is not a feature of the mark.
Goods and ServicesPharmaceutical preparations for the treatment of mitochondrial disorders; Pharmaceutical preparations and substances for treatment of genetic diseases; pharmaceutical preparations for the treatment of diseases or dysfunction of the mitochondria; pharmaceutical preparations featuring cell penetrating peptides for use in the treatment of genetic disorders; pharmaceuticals that treat genetic diseases by use of carrier proteins; pharmaceutical preparations for the treatment of ataxia; pharmaceutical preparations for the treatment of Friedreich's Ataxia; pharmaceutical preparations for protein replacement therapy
Indication of Colors claimedThe color(s) black, white, blue and teal is/are claimed as a feature of the mark.
NOT AVAILABLE"THERAPEUTICS"
Goods and ServicesPharmaceutical research and development; research and development in the pharmaceutical and biotechnology fields; research in the field of pharmaceuticals and drugs; conducting genomic analysis, pre-clinical studies and clinical trials for others in the field of pharmaceutical preparations for treatment of diseases

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, August 14, 2020
Primary Code005
First Use Anywhere DateMonday, October 2, 2023
First Use In Commerce DateMonday, October 2, 2023

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, August 14, 2020
Primary Code042
First Use Anywhere DateFriday, August 21, 2020
First Use In Commerce DateFriday, August 21, 2020

Trademark Owner History


Party NameLARIMAR THERAPEUTICS, INC.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressBALA CYNWYD, PA 19004

Party NameLARIMAR THERAPEUTICS, INC.
Party Type21 - New Owner After Publication
Legal Entity Type03 - Corporation
AddressBALA CYNWYD, PA 19004

Party NameChondrial Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBala Cynwyd, PA 19004

Party NameChondrial Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBala Cynwyd, PA 19004

Trademark Events


Event DateEvent Description
Tuesday, July 21, 2020NEW APPLICATION ENTERED
Friday, August 7, 2020TEAS VOLUNTARY AMENDMENT RECEIVED
Friday, August 7, 2020TEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED
Friday, August 14, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, August 15, 2020NOTICE OF DESIGN SEARCH CODE E-MAILED
Thursday, October 29, 2020ASSIGNED TO EXAMINER
Friday, November 6, 2020PRIORITY ACTION WRITTEN
Friday, November 6, 2020PRIORITY ACTION E-MAILED
Friday, November 6, 2020NOTIFICATION OF PRIORITY ACTION E-MAILED
Monday, November 30, 2020EXAMINERS AMENDMENT -WRITTEN
Monday, November 30, 2020EXAMINERS AMENDMENT E-MAILED
Monday, November 30, 2020NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Monday, November 30, 2020ASSIGNED TO LIE
Monday, November 30, 2020EXAMINER'S AMENDMENT ENTERED
Tuesday, December 1, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, December 16, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, January 5, 2021PUBLISHED FOR OPPOSITION
Tuesday, January 5, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 2, 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, June 16, 2021AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Wednesday, September 1, 2021SOU TEAS EXTENSION RECEIVED
Wednesday, September 1, 2021SOU EXTENSION 1 FILED
Wednesday, September 1, 2021SOU EXTENSION 1 GRANTED
Friday, September 3, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, February 25, 2022SOU TEAS EXTENSION RECEIVED
Friday, February 25, 2022SOU EXTENSION 2 FILED
Friday, February 25, 2022SOU EXTENSION 2 GRANTED
Tuesday, March 1, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, September 1, 2022SOU TEAS EXTENSION RECEIVED
Thursday, September 1, 2022SOU EXTENSION 3 FILED
Thursday, September 1, 2022SOU EXTENSION 3 GRANTED
Saturday, September 3, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, February 28, 2023SOU TEAS EXTENSION RECEIVED
Tuesday, February 28, 2023SOU EXTENSION 4 FILED
Monday, March 13, 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, March 14, 2023SOU EXTENSION 4 GRANTED
Wednesday, March 15, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, September 1, 2023SOU TEAS EXTENSION RECEIVED
Friday, September 1, 2023SOU EXTENSION 5 FILED
Tuesday, September 5, 2023SOU EXTENSION 5 GRANTED
Wednesday, September 6, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, January 18, 2024USE AMENDMENT FILED
Thursday, January 18, 2024TEAS STATEMENT OF USE RECEIVED
Monday, January 22, 2024STATEMENT OF USE PROCESSING COMPLETE
Tuesday, February 20, 2024ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Wednesday, February 21, 2024NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, March 26, 2024REGISTERED-PRINCIPAL REGISTER
Tuesday, March 26, 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED